Susquehanna International Group
GH icon

Susquehanna International Group’s Guardant Health GH Stock Holding History

Susquehanna International Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.6M Buy
644,138
+568,149
+748% +$61.8M 0.01% 989
2026
Q1 		$7.02M Buy
75,989
+72,683
+2,199% +$7.3M ﹤0.01% 3657
2025
Q4 		$338K Sell
3,306
-28,380
-90% -$2.54M ﹤0.01% 9672
2025
Q3 		$1.98M Sell
31,686
-151,718
-83% -$8.25M ﹤0.01% 5819
2025
Q2 		$9.54M Sell
183,404
-12,140
-6% -$542K ﹤0.01% 2897
2025
Q1 		$8.33M Buy
195,544
+143,710
+277% +$6.2M ﹤0.01% 2778
2024
Q4 		$1.58M Sell
51,834
-22,220
-30% -$625K ﹤0.01% 5827
2024
Q3 		$1.7M Buy
+74,054
New +$2.1M ﹤0.01% 5620
2024
Q2 		– Sell
-223,585
Closed -$5.21M – 12451
2024
Q1 		$4.61M Buy
223,585
+68,740
+44% +$1.47M ﹤0.01% 3758
2023
Q4 		$4.19M Sell
154,845
-38,086
-20% -$999K ﹤0.01% 4014
2023
Q3 		$5.72M Buy
192,931
+51,782
+37% +$1.82M ﹤0.01% 3309
2023
Q2 		$5.05M Sell
141,149
-203,533
-59% -$5.85M ﹤0.01% 3519
2023
Q1 		$8.08M Buy
344,682
+195,496
+131% +$5.58M ﹤0.01% 2764
2022
Q4 		$4.06M Buy
149,186
+104,660
+235% +$4.79M ﹤0.01% 3558
2022
Q3 		$2.4M Sell
44,526
-86,270
-66% -$4.43M ﹤0.01% 4563
2022
Q2 		$5.28M Buy
130,796
+92,569
+242% +$4.59M ﹤0.01% 3100
2022
Q1 		$2.53M Sell
38,227
-7,208
-16% -$493K ﹤0.01% 4957
2021
Q4 		$4.54M Buy
45,435
+42,754
+1,595% +$4.42M ﹤0.01% 3911
2021
Q3 		$335K Buy
+2,681
New +$319K ﹤0.01% 10336
2021
Q2 		– Sell
-1,761
Closed -$237K – 12797
2021
Q1 		$269K Sell
1,761
-3,530
-67% -$534K ﹤0.01% 10830
2020
Q4 		$682K Buy
5,291
+3,046
+136% +$350K ﹤0.01% 7610
2020
Q3 		$251K Sell
2,245
-188,270
-99% -$17.2M ﹤0.01% 9057
2020
Q2 		$15.5M Buy
190,515
+98,419
+107% +$7.93M ﹤0.01% 1672
2020
Q1 		$6.41M Sell
92,096
-81,310
-47% -$6.24M ﹤0.01% 2258
2019
Q4 		$13.6M Sell
173,406
-49,106
-22% -$3.54M ﹤0.01% 1785
2019
Q3 		$14.2M Buy
222,512
+139,931
+169% +$12.3M ﹤0.01% 1628
2019
Q2 		$7.13M Buy
82,581
+41,246
+100% +$3.15M ﹤0.01% 2275
2019
Q1 		$3.17M Buy
+41,335
New +$2.29M ﹤0.01% 3050

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Susquehanna International Group's GH Position: Q2 2026 in Review

Susquehanna International Group increased its Guardant Health (GH) stake by 748% in Q2 2026, buying an estimated $61.8M and bringing the position to 644,138 shares worth $96.6M. The position accounts for 0.01% of the portfolio, ranked #989.

Susquehanna International Group first reported a position in GH in Q1 2019 and has held it in 28 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Susquehanna International Group held 644,138 shares of Guardant Health worth $96.6M as of Q2 2026.
  • Susquehanna International Group bought 568,149 Guardant Health shares in Q2 2026, an estimated $61.8M.
  • Guardant Health made up 0.01% of Susquehanna International Group's portfolio in Q2 2026, its #989 holding.
  • Susquehanna International Group first reported a position in Guardant Health in Q1 2019 and has held it in 28 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.